Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients

Cancer Chemotherapy and Pharmacology

Volumn 76, Issue 5, 2015, Pages 957-967

  Bulten, Ben F ^a,b   Verberne, Hein J ^c   Bellersen, Louise ^b   Oyen, Wim J G ^b   Sabaté Llobera, Aida ^b,d   Mavinkurve Groothuis, Annelies M C ^e   Kapusta, Livia ^b,f   Van Laarhoven, Hanneke W M ^b,c   De Geus Oei, Lioe Fee ^a,b,g  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e Department of Radiation Oncology   (Netherlands)

^f TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

2D strain imaging; 123I mIBG scintigraphy; Anthracyclines; Biomarkers; Breast cancer; Cardiotoxicity

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FIBROBLAST GROWTH FACTOR 6; GALECTIN 3; INTERLEUKIN 6; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1; (3 IODOBENZYL)GUANIDINE; GLUCOSE BLOOD LEVEL; LIPID; PLASMA PROTEIN; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; TAXOID;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVOR; CARDIOTOXICITY; CARDIOVASCULAR PARAMETERS; FEMALE; GLOBAL LONGITUDINAL STRAIN; GLOBAL RADIAL STRAIN; HEART MEDIASTINUM RATIO; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETERS; TREATMENT DURATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; ADVERSE EFFECTS; ANALYSIS; BLOOD; BREAST NEOPLASMS; CHEMICALLY INDUCED; COMPLICATION; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART DISEASE; MIDDLE AGED; NEOADJUVANT THERAPY; OBSERVER VARIATION; REPRODUCIBILITY; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMARKERS; BLOOD GLUCOSE; BLOOD PROTEINS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; IODINE RADIOISOTOPES; LIPIDS; MIDDLE AGED; NEOADJUVANT THERAPY; OBSERVER VARIATION; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TAXOIDS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84944720990     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-015-2874-9     Document Type: Article

References (38)

1. Aggarwal A, Esler MD, Socratous F, Kaye DM (2001) Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. J Am Coll Cardiol 37:1246-1251
2. Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, Unlu M, Estorch M, Banerjee G, Jacobson AF (2008) I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 35:535-546
3. Altena R, Perik PJ, van Veldhuisen DJ, de Vries EG, Gietema JA (2009) Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncol 10:391-399
4. Appel JM, Sogaard P, Mortensen CE, Skagen K, Nielsen DL (2011) Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer. J Am Soc Echocardiogr 24:200-206
5. Armenian SH, Gelehrter SK, Vase T, Venkatramani R, Landier W, Wilson KD, Herrera C, Reichman L, Menteer JD, Mascarenhas L, Freyer DR, Venkataraman K, Bhatia S (2014) Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors. Clin Cancer Res 20:6314-6323
6. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ (2010) Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 55:2769-2777
7. Braunwald E (2008) Biomarkers in heart failure. N Engl J Med 358:2148-2159
8. Bryg RJ, Williams GA, Labovitz AJ (1987) Effect of aging on left ventricular diastolic filling in normal subjects. Am J Cardiol 59:971-974
9. Bulten BF, Mavinkurve-Groothuis AM, de Geus-Oei LF, de Haan AF, de Korte CL, Bellersen L, van Laarhoven HW, Kapusta L (2014) Early myocardial deformation abnormalities in breast cancer survivors. Breast Cancer Res Treat 146:127-135
10. Bulten BF, van der Palen RL, van Laarhoven HW, Kapusta L, Mavinkurve-Groothuis AM, de Geus-Oei LF (2012) Interobserver variability of heart-to-mediastinum ratio in I-123 MIBG sympathetic imaging. Curr Cardiol Rep 14:389-390 (author reply 391)
11. Cardoso F, Costa A, Norton L, Senkus E, Aapro M, Andre F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordstrom EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E (2014) ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast 23:489-502
12. Carrio I (2001) Cardiac neurotransmission imaging. J Nucl Med 42:1062-1076
13. Chen J, Folks RD, Verdes L, Manatunga DN, Jacobson AF, Garcia EV (2012) Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake. J Nucl Cardiol 19:92-99
14. Chen W, Cao Q, Dilsizian V (2011) Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections. Curr Cardiol Rep 13:132-137
15. Chirumamilla A, Travin MI (2011) Cardiac applications of 123I-mIBG imaging. Semin Nucl Med 41:374-387
16. Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schafers M, Somsen GA, Unlu M, Verberne HJ (2010) Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 37:1802-1812
17. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB (2008) Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 26:3777-3784
18. Giantris A, Abdurrahman L, Hinkle A, Asselin B, Lipshultz SE (1998) Anthracycline-induced cardiotoxicity in children and young adults. Crit Rev Oncol Hematol 27:53-68
19. Gutierrez-Chico JL, Zamorano JL, Perez de Isla L, Orejas M, Almeria C, Rodrigo JL, Ferreiros J, Serra V, Macaya C (2005) Comparison of left ventricular volumes and ejection fractions measured by three-dimensional echocardiography versus by two-dimensional echocardiography and cardiac magnetic resonance in patients with various cardiomyopathies. Am J Cardiol 95:809-813
20. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J (2010) Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 55:2212-2221
21. Ky B, French B, Ruparel K, Sweitzer NK, Fang JC, Levy WC, Sawyer DB, Cappola TP (2011) The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure. J Am Coll Cardiol 58:386-394
22. Ky B, Putt M, Sawaya H, French B, Januzzi JL Jr, Sebag IA, Plana JC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M (2014) Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J Am Coll Cardiol 63:809-816
23. Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD (2005) Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2629-2636
24. Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y, Liu LF (2007) Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res 67:8839-8846
25. Marwick TH (2006) Measurement of strain and strain rate by echocardiography: ready for prime time? J Am Coll Cardiol 47:1313-1327
26. McBride GB (2005) A proposal for strength-of-agreement criteria for Lin's concordance correlation coefficient. In: MO Health (ed) National Institute of Water & Atmospheric Research Ltd. Hamilton, New Zealand, pp 1-10
27. Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A, Gralow J, Hortobagyi GN, Moy B, Yee D, Brundage SB, Danso MA, Wilcox M, Smith IE (2014) Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:3307-3329
28. Radulescu D, Pripon S, Radulescu LI, Duncea C (2008) Left ventricular diastolic performance in breast cancer survivors treated with anthracyclines. Acta Cardiol 63:27-32
29. Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL (2010) Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail 12:826-832
30. Somsen GA, Verberne HJ, Fleury E, Righetti A (2004) Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies. J Nucl Cardiol 11:126-133
31. Stoodley PW, Richards DA, Hui R, Boyd A, Harnett PR, Meikle SR, Clarke J, Thomas L (2011) Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. Eur J Echocardiogr 12:945-952
32. Takemura G, Fujiwara H (2007) Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49:330-352
33. Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, Masuda M, Okuda K, Iwasaki Y, Yasui T, Hori M, Fukunami M (2009) Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol 53:426-435
34. van Boxtel W, Bulten BF, Mavinkurve-Groothuis AM, Bellersen L, Mandigers CM, Joosten LA, Kapusta L, de Geus-Oei LF, van Laarhoven HW (2015) New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin, and cyclophosphamide. Biomarkers 20(2):143-148. doi: 10.3109/1354750X.2015.1040839
35. Veltman CE, Boogers MJ, Meinardi JE, Al Younis I, Dibbets-Schneider P, Van der Wall EE, Bax JJ, Scholte AJ (2012) Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging 39:1599-1608
36. Wood PW, Choy JB, Nanda NC, Becher H (2014) Left ventricular ejection fraction and volumes: it depends on the imaging method. Echocardiography 31:87-100
37. Yeh ET, Bickford CL (2009) Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53:2231-2247
38. Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET (2012) Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 18:1639-1642